+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 94 Pages
  • Global
From
South Africa Biopharmaceuticals Market - Industry Outlook & Forecast 2023-2028 - Product Thumbnail Image

South Africa Biopharmaceuticals Market - Industry Outlook & Forecast 2023-2028

  • Report
  • August 2023
  • 202 Pages
  • South Africa
From
Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 580 Pages
  • Global
From
Biopharmaceuticals - A Global Market Overview - Product Thumbnail Image

Biopharmaceuticals - A Global Market Overview

  • Report
  • February 2025
  • 225 Pages
  • Global
From
Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Insight, 2025 - Product Thumbnail Image

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Diffuse Large B-Cell Lymphoma Therapeutics Market Report 2025 - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Non Hodgkin Lymphoma (NHL) Market Report 2025 - Product Thumbnail Image

Non Hodgkin Lymphoma (NHL) Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 71 Pages
  • Global
From
Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 119 Pages
  • Global
From
Asia Pacific Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

Asia Pacific Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • October 2021
  • 124 Pages
  • Asia Pacific
From
North America Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

North America Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • October 2021
  • 110 Pages
  • North America
From
Europe Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

Europe Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • October 2021
  • 125 Pages
  • Europe
From
LAMEA Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

LAMEA Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • October 2021
  • 124 Pages
  • Africa, Middle East
From
Biosimilars World Market - Product Thumbnail Image

Biosimilars World Market

  • Report
  • January 2023
  • 28 Pages
  • Global
From
Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players, and Key Geographical Regions, 2022-2032 - Product Thumbnail Image

Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players, and Key Geographical Regions, 2022-2032

  • Report
  • February 2022
  • 421 Pages
  • Global
From
Hematological Disorders Diagnostic And Therapeutic Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hematological Disorders Diagnostic And Therapeutic Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • February 2022
  • 95 Pages
  • Global
From
Gynecology Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Gynecology Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 100 Pages
  • Global
From
Marburgvirus Infections (Marburg Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Marburgvirus Infections (Marburg Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 99 Pages
  • Global
From
Lassa Fever (Lassa Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Lassa Fever (Lassa Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 65 Pages
  • Global
From
Schistosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Schistosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 40 Pages
  • Global
From
Loading Indicator